MW This industrials company is joining the S&P 500 soon
By Claudia Assis
Lennox is in, Catalent is out as deal with Novo Nordisk closes
Heating and air-conditioning equipment maker Lennox International Inc. is replacing contract drug maker Catalent Inc. in the S&P 500, S&P Dow Jones Indices said late Wednesday.
Novo Nordisk's controlling shareholder, Novo Holdings, has bought Catalent in a $16.5 billion deal that closed earlier Wednesday.
At the time the deal was announced, Novo Nordisk (DK:NOVO.B), the maker of diabetes drugs Wegovy and others, said it was "aligned" with its strategy of reaching more people living with diabetes and obesity and it would enable "an expansion of the manufacturing capacity."
S&P Dow Jones Indices also said that Bill Holdings Inc. $(BILL)$ is the company replacing Lennox International $(LII)$ in the S&P MidCap 400. The changes are effective at the open on Monday.
Shares of Lennox International rose nearly 4% in the extended session Wednesday, after ending the regular trading day down 2.9%. The stock has gained nearly 43% this year, compared with an advance of 23% for the S&P 500 index SPX.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 18, 2024 17:56 ET (22:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。